Cannabis Stocks Are Climbing — And the Biggest Catalyst Hasn’t Even Arrived Yet
Cannabis stocks remain in focus as a key federal hearing approaches, with Green Thumb Industries and Curaleaf among closely watched sector participants.
Why Are NYSE Composite Cannabis Penny Stocks Swinging on Rescheduling?
Cannabis penny stock activity remains volatile as rescheduling discussions, regulatory hearings, and industry developments continue drawing attention across the NYSE Composite.
Cannabis Has Dozens Of Public Companies. Wall Street Acts Like It Has Seven.
Cannabis stocks have rallied 104% in a year, but only seven North American operators clear the institutional threshold that matters to Wall Street.
Why Are Cannabis Stocks Gaining Attention Right Now
Cannabis companies attract renewed attention as reclassification discussions progress and upcoming regulatory proceedings shape expectations across the evolving industry.
Robinhood Is Opening the Door to U.S. Cannabis With Reform On the Horizon
Trulieve, Curaleaf, and Green Thumb Industries showed up on the app this week as the federal government inches toward reclassifying recreational marijuana.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Cannabis Stocks Are Climbing — And the Biggest Catalyst Hasn’t Even Arrived Yet
Cannabis stocks remain in focus as a key federal hearing approaches, with Green Thumb Industries and Curaleaf among closely watched sector participants.
Why Are NYSE Composite Cannabis Penny Stocks Swinging on Rescheduling?
Cannabis penny stock activity remains volatile as rescheduling discussions, regulatory hearings, and industry developments continue drawing attention across the NYSE Composite.
Cannabis Has Dozens Of Public Companies. Wall Street Acts Like It Has Seven.
Cannabis stocks have rallied 104% in a year, but only seven North American operators clear the institutional threshold that matters to Wall Street.
Why Are Cannabis Stocks Gaining Attention Right Now
Cannabis companies attract renewed attention as reclassification discussions progress and upcoming regulatory proceedings shape expectations across the evolving industry.
‘Devastating’: Retired firefighter says he lost most of his retirement savings investing in stocks that were targeted by a famous short-seller
He turned $110K into $190K, then watched his savings vanish after public criticism from from Citron Research’s Andrew Left.
Retired firefighter says he lost most of his savings investing in stocks that were targeted by famous short-seller
He turned $110K into $190K, then watched his savings vanish after public criticism from from Citron Research’s Andrew Left.
Canopy Growth’s Stock Just Dropped — Here’s Why I’m Still Not Buying
For anyone who has observed Canopy Growth (NASDAQ: CGC) during the past few years, it won’t be shocking to learn that the marijuana company’s stock is diving in May. Since the start of the month, it’s …
Auxly Cannabis is still undervalued, this analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $0.25 target on Auxly Cannabis Group (Auxly Cannabis Group Stock Quote, Chart, News, Analysts, Financials TSX:XLY) in a May 14 report after …
Buy this cannabis stock for a double, analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $3.25 target on Organigram Holdings (Organigram Global Stock Quote, Chart, News, Analysts, Financials TSX:OGI) in a M …
Recent Comments